The burden of interstitial lung disease has increased globally over the past 30 years and is positively linked to socio-demographic index (SDI).
New-onset interstitial lung disease can be detected up to 10 years after initial negative screening in patients with systemic sclerosis, with a higher mortality risk vs those without lung involvement.
The ATS/ERS 2025 statement on interstitial pneumonia classification updates the 2013 statement, with insights on secondary ...
Slower oxygen recovery after a 6-minute walk test may predict poorer lung function and a higher risk for disease progression in patients with fibrotic interstitial lung disease.
Despite the development of cutting-edge genetic testing techniques and considerable progress in our understanding of the genetic basis of idiopathic pulmonary fibrosis (IPF), missing heritability and ...
The main pulmonary artery diameter, esophageal dilatation, and ILD score are independent risk factors for 5-year all-cause mortality in patients with connective tissue disease-associated PAH.
Following the presentations, the posters will be available on Liquidia’s website at https://liquidia.com/publications.